Why substance use treatment is underprovided

As my recent post documented, SUD treatment is both effective for patients and has large, positive spillovers to society. So why is it underfunded and underprovided? In my latest AcademyHealth post, I offer some answers.

@afrakt

Austin Frakt

Austin Frakt, PhD, is co-Editor-in-Chief of The Incidental Economist. His day job is Vice President and Chief Research Officer at Joint Commission. He is also Associate Director of the Partnered Evidence-based Policy Resource Center at the Boston VA Healthcare System, U.S. Department of Veterans Affairs; Principal Research Scientist with the Department of Health Policy and Management, Harvard T.H. Chan School of Public Health; and Editor in Chief of the journal Health Services Research.

Hidden information below

Austin Frakt

Austin Frakt, PhD, is co-Editor-in-Chief of The Incidental Economist. His day job is Vice President and Chief Research Officer at Joint Commission. He is also Associate Director of the Partnered Evidence-based Policy Resource Center at the Boston VA Healthcare System, U.S. Department of Veterans Affairs; Principal Research Scientist with the Department of Health Policy and Management, Harvard T.H. Chan School of Public Health; and Editor in Chief of the journal Health Services Research.

Subscribe

Email Address*